Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2000
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits ; day:21 ; month:6 ; year:2017 ; pages:1-9
Molecular diagnosis & therapy ; (21.6.2017), 1-9
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ma, Wanlong
- Beteiligte Personen und Organisationen
-
Brodie, Steven
Agersborg, Sally
Funari, Vincent A.
Albitar, Maher
SpringerLink (Online service)
- DOI
-
10.1007/s40291-017-0290-z
- URN
-
urn:nbn:de:1111-201709119540
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Wanlong
- Brodie, Steven
- Agersborg, Sally
- Funari, Vincent A.
- Albitar, Maher
- SpringerLink (Online service)
Ähnliche Objekte (12)
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
FDA
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
FDA
FDA-cleared home sleep apnea testing devices
Levels of autonomy in FDA-cleared surgical robots: a systematic review
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
KRAS and BRAF mutational status in colon cancer from Albanian patients
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
The clinician-AI interface: intended use and explainability in FDA-cleared AI devices for medical image interpretation
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Survival kits
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants